Our timing guide for semaglutide covers this in more detail
Plan administrators focus on whether the medication addresses medical care, not general wellness or appearance-related goals
The use of GLP-1 analogues for weight loss in adolescents or children is not currently approved by regulatory authorities
It is important that participants in a clinical trial do not stop taking retatrutide without first consulting their trial team , as this may have implications for trial integrity and individual health outcomes
The appearance of cellulite is caused by the interplay between your fat cells and the connective tissue that holds them in place
In small proof-of-concept phase 2 randomized controlled trials (RCTs) in patients with biopsy-confirmed MASH, liraglutide at 1.8 mg/day for 48 weeks (201), semaglutide at 0.4 mg/day for 72 weeks (202), and tirzepatide at 15 mg/week for 52 weeks (203) have been reported to achieve placebo-corrected percentages of participants meeting the criteria for resolution of MASH without worsening fibrosis by 30% (P = 0.019), 42% (P 10%) may lead to diabetes remission (237)